drugset / Trial / NCT01579500
Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients
Phase 4
Completed
40 enrolled
Catholic University of Korea Saint Paul's Hospital
Medy-Tox · collabNational Health Insurance Service Ilsan Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether botulinum toxin A is effective in the treatment of neuropathic pain in spinal cord injury patients.
Timeline
- Start
- 2012-04
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | — | Subcutaneous |